This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

D. Eugene Strandness, Jr., MD

JAMA. 1970;213(1):86-88.

Abstract
The usefulness of isoxsuprine hyldochloride for the treatment of intermittent claudication was studied in 20 patients with arteriosclerosis obliterans. The study consisted of two four-week periods during which the patient was treated with both drug and placebo, the order of which was randomly assigned. The pattern of the postexercise hyperemic response was measured by the ankle systolic blood pressure response to exercise. A comparison of the drug and placebo treatment periods indicated that isoxsuprine did not improve the hyperemic response to exercise. On the basis of these data, it was not possible to demonstrate that isoxsuprine was useful in the treatment of intermittent claudication.

Author Affiliations
From the Peripheral Vascular Service, Veterans Administration Hospital, and the Department of Surgery, University of Washington School of Medicine, Seattle.

Footnotes
Reprint requests to 4435 Beacon Ave S, Seattle 98108 (Dr. Strandness).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ability of Ankle-Brachial Index to Detect Lower-Extremity Atherosclerotic Disease Progression
McLafferty et al.
Arch Surg 1997;132:836-841.
ABSTRACT  

Failure of Vasodilator Drugs in Arteriosclerosis Obliterans
COFFMAN and MANNICK
ANN INTERN MED 1972;76:35-39.
ABSTRACT